table of content
1 Introduction to Research & Analysis Reports
1.1 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Overall Market Size
2.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size: 2022 VS 2029
2.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, Prospects & Forecasts: 2018-2029
2.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales: 2018-2029
3 Company Landscape
3.1 Top T-Cell & NK-Cell Engaging Bispecific Antibodies Players in Global Market
3.2 Top Global T-Cell & NK-Cell Engaging Bispecific Antibodies Companies Ranked by Revenue
3.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Companies
3.4 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Companies
3.5 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 T-Cell & NK-Cell Engaging Bispecific Antibodies Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers T-Cell & NK-Cell Engaging Bispecific Antibodies Product Type
3.8 Tier 1, Tier 2 and Tier 3 T-Cell & NK-Cell Engaging Bispecific Antibodies Players in Global Market
3.8.1 List of Global Tier 1 T-Cell & NK-Cell Engaging Bispecific Antibodies Companies
3.8.2 List of Global Tier 2 and Tier 3 T-Cell & NK-Cell Engaging Bispecific Antibodies Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size Markets, 2022 & 2029
4.1.2 Recombinant Monoclonal Antibodies
4.1.3 In-House Bispecific Antibodies
4.2 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue & Forecasts
4.2.1 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2018-2023
4.2.2 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2024-2029
4.2.3 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2018-2029
4.3 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales & Forecasts
4.3.1 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2018-2023
4.3.2 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2024-2029
4.3.3 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2018-2029
4.4 By Type - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2022 & 2029
5.1.2 Immunotherapy of Cancer
5.1.3 Clinical Experiment
5.2 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue & Forecasts
5.2.1 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2018-2023
5.2.2 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2024-2029
5.2.3 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2018-2029
5.3 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales & Forecasts
5.3.1 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2018-2023
5.3.2 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2024-2029
5.3.3 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2018-2029
5.4 By Application - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2022 & 2029
6.2 By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue & Forecasts
6.2.1 By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2018-2023
6.2.2 By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2024-2029
6.2.3 By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share, 2018-2029
6.3 By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales & Forecasts
6.3.1 By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2018-2023
6.3.2 By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2024-2029
6.3.3 By Region - Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2018-2029
6.4.2 By Country - North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2018-2029
6.4.3 US T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.4.4 Canada T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.4.5 Mexico T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2018-2029
6.5.2 By Country - Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2018-2029
6.5.3 Germany T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.5.4 France T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.5.5 U.K. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.5.6 Italy T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.5.7 Russia T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.5.8 Nordic Countries T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.5.9 Benelux T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2018-2029
6.6.2 By Region - Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2018-2029
6.6.3 China T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.6.4 Japan T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.6.5 South Korea T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.6.6 Southeast Asia T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.6.7 India T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2018-2029
6.7.2 By Country - South America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2018-2029
6.7.3 Brazil T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.7.4 Argentina T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, 2018-2029
6.8.3 Turkey T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.8.4 Israel T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.8.5 Saudi Arabia T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
6.8.6 UAE T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 AbbVie
7.1.1 AbbVie Company Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.1.4 AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.1.5 AbbVie Key News & Latest Developments
7.2 Astellas Pharma
7.2.1 Astellas Pharma Company Summary
7.2.2 Astellas Pharma Business Overview
7.2.3 Astellas Pharma T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.2.4 Astellas Pharma T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.2.5 Astellas Pharma Key News & Latest Developments
7.3 GEMoaB Monoclonals
7.3.1 GEMoaB Monoclonals Company Summary
7.3.2 GEMoaB Monoclonals Business Overview
7.3.3 GEMoaB Monoclonals T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.3.4 GEMoaB Monoclonals T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.3.5 GEMoaB Monoclonals Key News & Latest Developments
7.4 Immunocore
7.4.1 Immunocore Company Summary
7.4.2 Immunocore Business Overview
7.4.3 Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.4.4 Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.4.5 Immunocore Key News & Latest Developments
7.5 Molecular Partners
7.5.1 Molecular Partners Company Summary
7.5.2 Molecular Partners Business Overview
7.5.3 Molecular Partners T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.5.4 Molecular Partners T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.5.5 Molecular Partners Key News & Latest Developments
7.6 Roche
7.6.1 Roche Company Summary
7.6.2 Roche Business Overview
7.6.3 Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.6.4 Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.6.5 Roche Key News & Latest Developments
7.7 AstraZeneca
7.7.1 AstraZeneca Company Summary
7.7.2 AstraZeneca Business Overview
7.7.3 AstraZeneca T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.7.4 AstraZeneca T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.7.5 AstraZeneca Key News & Latest Developments
7.8 Merck & Co.
7.8.1 Merck & Co. Company Summary
7.8.2 Merck & Co. Business Overview
7.8.3 Merck & Co. T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.8.4 Merck & Co. T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.8.5 Merck & Co. Key News & Latest Developments
7.9 Pfizer
7.9.1 Pfizer Company Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.9.4 Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.9.5 Pfizer Key News & Latest Developments
7.10 Eli Lilly
7.10.1 Eli Lilly Company Summary
7.10.2 Eli Lilly Business Overview
7.10.3 Eli Lilly T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.10.4 Eli Lilly T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.10.5 Eli Lilly Key News & Latest Developments
7.11 IGM Biosciences
7.11.1 IGM Biosciences Company Summary
7.11.2 IGM Biosciences T-Cell & NK-Cell Engaging Bispecific Antibodies Business Overview
7.11.3 IGM Biosciences T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.11.4 IGM Biosciences T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.11.5 IGM Biosciences Key News & Latest Developments
7.12 Novartis
7.12.1 Novartis Company Summary
7.12.2 Novartis T-Cell & NK-Cell Engaging Bispecific Antibodies Business Overview
7.12.3 Novartis T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.12.4 Novartis T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.12.5 Novartis Key News & Latest Developments
7.13 BenHealth Biopharmaceuticals
7.13.1 BenHealth Biopharmaceuticals Company Summary
7.13.2 BenHealth Biopharmaceuticals T-Cell & NK-Cell Engaging Bispecific Antibodies Business Overview
7.13.3 BenHealth Biopharmaceuticals T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.13.4 BenHealth Biopharmaceuticals T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.13.5 BenHealth Biopharmaceuticals Key News & Latest Developments
7.14 CytomX Therapeutics
7.14.1 CytomX Therapeutics Company Summary
7.14.2 CytomX Therapeutics Business Overview
7.14.3 CytomX Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.14.4 CytomX Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.14.5 CytomX Therapeutics Key News & Latest Developments
7.15 Janssen
7.15.1 Janssen Company Summary
7.15.2 Janssen Business Overview
7.15.3 Janssen T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.15.4 Janssen T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.15.5 Janssen Key News & Latest Developments
7.16 Lava Therapeutics
7.16.1 Lava Therapeutics Company Summary
7.16.2 Lava Therapeutics Business Overview
7.16.3 Lava Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.16.4 Lava Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.16.5 Lava Therapeutics Key News & Latest Developments
7.17 MacroGenics
7.17.1 MacroGenics Company Summary
7.17.2 MacroGenics Business Overview
7.17.3 MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.17.4 MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.17.5 MacroGenics Key News & Latest Developments
7.18 Maverick Therapeutics
7.18.1 Maverick Therapeutics Company Summary
7.18.2 Maverick Therapeutics Business Overview
7.18.3 Maverick Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.18.4 Maverick Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.18.5 Maverick Therapeutics Key News & Latest Developments
7.19 VBL Therapeutics
7.19.1 VBL Therapeutics Company Summary
7.19.2 VBL Therapeutics Business Overview
7.19.3 VBL Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.19.4 VBL Therapeutics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.19.5 VBL Therapeutics Key News & Latest Developments
7.20 Amgen
7.20.1 Amgen Company Summary
7.20.2 Amgen Business Overview
7.20.3 Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Major Product Offerings
7.20.4 Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Revenue in Global (2018-2023)
7.20.5 Amgen Key News & Latest Developments
8 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Production Capacity, Analysis
8.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Production Capacity, 2018-2029
8.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Production Capacity of Key Manufacturers in Global Market
8.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 T-Cell & NK-Cell Engaging Bispecific Antibodies Supply Chain Analysis
10.1 T-Cell & NK-Cell Engaging Bispecific Antibodies Industry Value Chain
10.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Upstream Market
10.3 T-Cell & NK-Cell Engaging Bispecific Antibodies Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
